NF-ΚB in rheumatoid arthritis: A pivotal regulator of inflammation, hyperplasia, and tissue destruction

Arthritis Research

Volumn 3, Issue 4, 2001, Pages 200-206

  Makarov, S S ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Hyperplasia; Inflammation; Inhibitors; Nuclear factor NF B; Rheumatoid arthritis; Therapy

Indexed keywords

I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TRANSCRIPTION FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; CELL ACTIVATION; CELL ACTIVITY; CELL DIFFERENTIATION; CELL PROLIFERATION; DRUG EFFICACY; FEASIBILITY STUDY; FIBROBLAST; HELPER CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERPLASIA; INFLAMMATION; LYMPHOCYTE ACTIVATION; MOUSE; NONHUMAN; NOTE; OSTEOCLAST; OSTEOLYSIS; PATHOLOGY; RHEUMATOID ARTHRITIS; SYNOVIOCYTE; TISSUE INJURY;

ANIMALS; ARTHRITIS, RHEUMATOID; DISEASE MODELS, ANIMAL; HUMANS; HYPERPLASIA; JOINTS; NF-KAPPA B; SYNOVITIS;

EID: 0034942860     PISSN: 14659905     EISSN: None     Source Type: Journal    
DOI: 10.1186/ar300     Document Type: Note

References (61)

1. Nuclear factor-kappa B: A pivotal transcription factor in chronic inflammatory diseases
2. NF-kappa B: A key role in inflammatory diseases
3. NF-kappa B as a therapeutic target in chronic inflammation: Recent advances
4. The NF-kappa B and I kappa B proteins: New discoveries and insights
5. Phosphorylation meets ubiquitination: The control of NF-kappa B activity
6. Regulation of NF-kappa B activation by MAP kinase cascades
7. Activators and target genes of Rel/NF-kappa B transcription factors
8. NF-kappa B activation in human knee-joint synovial tissue during the early stage of joint inflammation
9. High DNA-binding activity of transcription factor NF-kappa B in synovial membranes of patients with rheumatoid arthritis
10. Nuclear factor-kappa B in rheumatoid synovium. Localization of p50 and p65
11. Activation of the transcription factor nuclear factor-kappa B in human inflamed synovial tissue
12. Constitutive transcription of the human interleukin-6 gene by rheumatoid synoviocytes: Spontaneous activation of NF-kappa B and CBF1
13. The effect of dexamethasone on the expression of activated NF-kappa B in adjuvant arthritis
14. NF-kappa B activation provides the potential link between inflammation and hyperplasia in the arthritic joint
15. Role of the proteasome and NF-kappa B in streptococcal cell wall-induced polyarthritis
16. AP-1 and NF-kappa B regulation in rheumatoid arthritis and murine collagen-induced arthritis
17. The regulation and roles of Rel/NF-kappa B transcription factors during lymphocyte activation
18. Transcriptional regulation of T lymphocyte development and function
19. A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function
20. TRANCE is a TNF family member that regulates dendritic cell and osteoclast function
21. T suppressor lymphocytes inhibit NF-kappa B-mediated transcription of CD86 gene in APC
22. N-Acetyl-L-cysteine inhibits primary human T cell responses at the dendritic cell level: Association with NF-kappa B inhibition
23. Genetic approaches in mice to understand Rel/NF-kappa B and I kappa B function: Transgenics and knockouts
24. Preferential role for NF-kappa B/Rel signaling in the type 1 but not type 2 T cell-dependent immune response in vivo
25. Essential role of T cell NF-kappa B activation in collagen-induced arthritis
26. Role of the guanosine triphosphatase Rac2 in T helper 1 cell differentiation
27. Efficient adenoviral infection with Ikappa B alpha reveals that macrophage tumor necrosis factor alpha production in rheumatoid arthritis is NF-kappa B dependent
28. GS: NF-kappa B regulation by Ikappa B kinase-2 in rheumatoid arthritis synoviocytes
29. NF-kappa B as a target for anti-inflammatory gene therapy: Suppression of inflammatory responses in monocytic and stromal cells by stable gene transfer of I kappa B alpha cDNA
30. NF-kappa B regulates VCAM-1 expression on fibroblast-like synoviocytes
31. Defining therapeutic targets by using adenovirus: Blocking NF-kappa B inhibits both inflammatory and destructive mechanisms in rheumatoid synovium but spares anti-inflammatory mediators
32. NF-kappa B is a target of AKT in anti-apoptotic PDGF signalling
33. NF-kappa B controls cell growth and differentiation through transcriptional regulation of cyclin D1
34. NF-kappa B function in growth control: Regulation of cyclin D1 expression and GO/G1-to-S-phase transition
35. Control of apoptosis by Rel/NF-kappa B transcription factors
36. Gene therapy that inhibits nuclear translocation of nuclear factor kappa B results in tumor necrosis factor alpha-induced apoptosis of human synovial fibroblasts
37. NF-kappa B activation by tumour necrosis factor requires the Akt serine-threonine kinase
38. Activation of phosphatidylinositol 3-kinase in response to interleukin-1 leads to phosphorylation and activation of the NF-kappa B p65/RelA subunit
39. Activation of NF-kappa B by bradykinin through a Galpha(q)- and Gbeta gamma-dependent pathway that involves phosphoinositide 3-kinase and Akt
40. Akt suppresses apoptosis by stimulating the trans-activation potential of the RelA/p65 subunit of NF-kappa B
41. HER-2/neu blocks tumor necrosis factor-induced apoptosis via the Akt/NF-kappa B pathway
42. Induction of NF-kappa B by the Akt/PKB kinase
43. The multiple roles of PTEN in tumor suppression
44. Identification of a novel PTEN mutation (L139X) in a patient with Cowden disease and Sjogren's syndrome
45. +/-mice
46. Increased phosphoinositide 3-kinase activity induces a lymphoproliferative disorder and contributes to tumor generation in vivo
47. Activation of synovial fibroblasts in rheumatoid arthritis: Lack of expression of the tumour suppressor PTEN at sites of invasive growth and destruction
48. Nuclear factor kappa B/p50 activates an element in the distal matrix metalloproteinase 1 promoter in interleukin-1beta-stimulated synovial fibroblasts
49. Synergistic upregulation of metalloproteinase-9 by growth factors and inflammatory cytokines: An absolute requirement for transcription factor NF-kappa B
50. Nuclear factor kappa B activity is essential for matrix metalloproteinase-1 and -3 upregulation in rabbit dermal fibroblasts
51. Effective adenoviral transfer of Ikappa B alpha into human fibroblasts and chondrosarcoma cells reveals that the induction of matrix metalloproteinases and proinflammatory cytokines is nuclear factor-kappa B dependent
52. Involvement of interleukin-8, vascular endothelial growth factor, and basic fibroblast growth factor in tumor necrosis factor alpha-dependent angiogenesis
53. Pathogenesis of bone erosions in rheumatoid arthritis
54. Bone resorption by osteoclasts
55. Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand
56. Osteopetrosis in mice lacking NF-kappa B1 and NF-kappa B2
57. Diverse agents act at multiple levels to inhibit the Rel/NF-kappa B signal transduction pathway
58. Distinct roles for the NF-kappaB1 (p50) and c-Rel transcription factors in inflammatory arthritis
59. Suppressed severity of collagen-induced arthritis by in vivo transfection of nuclear factor kappa B decoy oligodeoxy-nucleotides as a gene therapy
60. Selective inhibition of NF-kappa B activation by a peptide that blocks the interaction of NEMO with the Ikappa B kinase complex
61. Gene therapy for rheumatoid arthritis: Preclinical studies